Gil Kristen 4

What Happened

• Gil Kristen, a director of UnitedHealth Group (UNH), was granted 320 deferred stock units (DSUs) on April 1, 2026. The Form 4 reports the acquisition at $0.00 (no cash exchanged) for a reported value of $0 on the filing.
• This transaction is an award/compensation grant to a board member rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-04-01; Reported acquisition price: $0.00.
• Shares/units granted: 320 deferred stock units (reported as "acquired" on the Form 4).
• Shares owned after transaction: Not specified in the provided filing data.
• Footnote: These are deferred stock units granted as regular quarterly director compensation. They vest immediately but must be retained until the director leaves the Board.
• Filing date: Form 4 filed 2026-04-06 (transaction reported for 2026-04-01). Investors should note the transaction and filing dates when assessing timeliness.

Context

• Deferred stock units are a common form of non-cash director compensation and do not represent an open-market purchase or sale. Because DSUs must be held until the director leaves the board, this award is largely administrative/compensation-related and not a clear bullish or bearish trading signal.